II. Indications
-
Opioid Induced Constipation (chronic non-Cancer Pain)
- Severe refractory Constipation due to Opioids
III. Contraindications
- Severe liver disease
IV. Mechanism
V. Dosing
VI. Efficacy
- See Gastrointestinal Opioid Antagonist
- Best efficacy in those on Opioids for >4 weeks
- Refractory Opioid Induced Constipation in Cancer and Palliative Care
- Both oral Naldemedine (Symproic) and SQ Methylnaltrexone (Relistor) are effective with benefits outweighing harms
- Brown (2023) Am Fam Physician 107(2):131-2 [PubMed]
VII. Adverse Effects
VIII. Safety
- Unknown safety in pregnancy
- Contraindicated in Lactation
IX. Drug Interactions
- Strong CYP3A4 inducers
- Strong CYP3A4 Inhibitors
- P-Glycoprotein Inhibitors
X. Resources
XI. References
- (2017) Presc Lett 24(12): 70
- Portenoy (2008) J Pain Symptom Manage 35(5): 458-68 [PubMed]
- Thomas (2008) N Engl J Med 358(22): 2332-43 [PubMed]
Images: Related links to external sites (from Bing)
Related Studies
symproic (on 1/1/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
SYMPROIC 0.2 MG TABLET | $13.31 each |